Armata Pharmaceuticals (ARMP) Gross Profit: 2013-2018
Historic Gross Profit for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to -$337,000.
- Armata Pharmaceuticals' Gross Profit fell 1785.00% to -$337,000 in Q4 2018 from the same period last year, while for Dec 2018 it was -$712,000, marking a year-over-year decrease of 719.13%. This contributed to the annual value of -$5.6 million for FY2024, which is 392.59% down from last year.
- According to the latest figures from Q4 2018, Armata Pharmaceuticals' Gross Profit is -$337,000, which was down 9.77% from -$307,000 recorded in Q3 2018.
- In the past 5 years, Armata Pharmaceuticals' Gross Profit registered a high of $143,000 during Q3 2015, and its lowest value of -$337,000 during Q4 2018.
- In the last 3 years, Armata Pharmaceuticals' Gross Profit had a median value of $28,000 in 2017 and averaged -$32,455.
- As far as peak fluctuations go, Armata Pharmaceuticals' Gross Profit surged by 3,333.33% in 2014, and later slumped by 1,785.00% in 2018.
- Armata Pharmaceuticals' Gross Profit (Quarterly) stood at $101,000 in 2014, then rose by 26.73% to $128,000 in 2015, then crashed by 82.81% to $22,000 in 2016, then decreased by 9.09% to $20,000 in 2017, then plummeted by 1,785.00% to -$337,000 in 2018.
- Its Gross Profit stands at -$337,000 for Q4 2018, versus -$307,000 for Q3 2018 and -$88,000 for Q2 2018.